Take two tablets and a selfie? Your doctor’s orders might one day include a smartphone video to make sure you took your medicine.
Smartphone apps that monitor pill-taking are now available, and researchers are testing how well they work when medication matters.
Experts have praised the efficiency, but some have said that the technology raises privacy and data security concerns.
Selfie medicine works like this: Open an app on your smartphone, show your pills, put them in your mouth and swallow. Do not forget to show your empty mouth to the camera to prove today’s dose is on its way. Then upload the video proof to the clinic.
Fans have said the technology addresses a big problem: About half of drugs for chronic conditions are not taken as prescribed because of cost, side effects or patient forgetfulness.
With treatment for opioid addiction, a skipped dose can mean a dangerous relapse.
The US National Institute on Drug Abuse is funding research to tailor a smartphone app for those patients and see if they will use it.
“If we can keep patients engaged, we can keep them in treatment longer,” said lead researcher Judith Tsui of the University of Washington School of Medicine in Seattle.
The next phase of her research is to compare a group of patients who use the monitoring app called emocha with those who do not to see if there is a difference.
At one Tennessee treatment center, some patients with opioid addiction are already using the app to upload selfies of their daily dose and answer questions about how they are doing.
“Every time they sign on, it allows us to capture data. Are they having cravings? Suicidal tendencies?” said Scott Olson, CEO of Dallas-based Pathway Healthcare, which is trying the app at its site in Jackson, Tennessee. “Maybe a phone call from a counselor might make the difference between staying clean and a relapse.”
Olson thinks insurers will pay for the service with more evidence.
For monitoring tuberculosis patients, health departments pay roughly US$35 to US$50 per patient each month for systems that include encrypted data storage. A small health department might pay as little as US$500 per month.
The idea of watching someone take their medicine — called directly observed therapy — has roots in tuberculosis, where one person’s forgetfulness can be serious for everyone. If patients do not take all their antibiotics, their infectious tuberculosis germs can get stronger, developing drug resistance and endangering the broader community.
However, taking a handful of pills daily for up to a year is difficult, so public health departments traditionally sent workers to people’s homes and workplaces to watch them take their doses.
Today, many tuberculosis patients prefer remote monitoring. Nurses like it too.
Nurse Peggy Cooley has used Skype for years to chat live with patients taking tuberculosis medicine.
“We can accomplish in a two-minute phone call something that might have taken an hour to do and most of that hour was in the car,” said Cooley, who works for the Tacoma-Pierce County Health Department in Washington state.
The new uploaded selfies do not need an appointment. They are a daily routine for many tuberculosis patients in Seattle, San Francisco, Los Angeles and Houston, Texas, where savings on mileage and worker time amounted to US$100,000 in a recent year.
In Boston; Albuquerque, New Mexico; and five other cities, researchers are studying whether the technology works for hepatitis C, a blood-borne virus that is surging among a new generation of injection drug users. New drugs for hepatitis C can cure, but they are expensive — US$75,000 for a 12-week course of treatment — so insurers want to make sure patients take them.
“I think it holds a lot of promise,” said researcher Alain Litwin of the University of South Carolina School of Medicine, who is testing whether patients do better when someone watches them take their pills.
What is next?
An insurer in Maryland plans to use the technology in diabetes and high blood pressure to make sure Medicare and Medicaid patients take their medicine.
Start-ups selling the apps have said that they could be used by faraway adult children monitoring an elderly parent’s daily pill-taking.
Experts worry about privacy, data security and penalties for poor pill-taking.
“That’s the biggest ick factor,” New York-based Hastings Center medical ethicist Carolyn Neuhaus said. “You can imagine a program where benefits are tied to compliance and the insurer says: ‘We won’t pay for medication anymore unless you’re taking it correctly.’”
Globally, the rapid spread of smartphones creates an opportunity to eradicate tuberculosis, the app developers have said.
However, eliminating tuberculosis might take simpler, cheaper technologies that can be scaled for millions of cases, said Daniel Chin (錢秉中), who leads tuberculosis eradication efforts for the Bill and Melinda Gates Foundation.
The group supports research in China and India on two homegrown technologies.
China’s tool, about the size of a child’s shoebox, reminds patients to take their pills and saves data for review.
In India, the government favors a blister pill pack printed with telephone numbers; a patient punches out a daily pill, then calls the revealed number.
Worldwide, tuberculosis kills more than 1.6 million people annually, even though most deaths are preventable with treatment.
“If we are going to eliminate the disease, we need technology,” said Richard Garfein of the University of California, San Diego School of Medicine, who helped develop one of the smartphone apps, SureAdhere.
The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
US President Donald Trump created some consternation in Taiwan last week when he told a news conference that a successful trade deal with China would help with “unification.” Although the People’s Republic of China has never ruled Taiwan, Trump’s language struck a raw nerve in Taiwan given his open siding with Russian President Vladimir Putin’s aggression seeking to “reunify” Ukraine and Russia. On earlier occasions, Trump has criticized Taiwan for “stealing” the US’ chip industry and for relying too much on the US for defense, ominously presaging a weakening of US support for Taiwan. However, further examination of Trump’s remarks in
As strategic tensions escalate across the vast Indo-Pacific region, Taiwan has emerged as more than a potential flashpoint. It is the fulcrum upon which the credibility of the evolving American-led strategy of integrated deterrence now rests. How the US and regional powers like Japan respond to Taiwan’s defense, and how credible the deterrent against Chinese aggression proves to be, will profoundly shape the Indo-Pacific security architecture for years to come. A successful defense of Taiwan through strengthened deterrence in the Indo-Pacific would enhance the credibility of the US-led alliance system and underpin America’s global preeminence, while a failure of integrated deterrence would
It is being said every second day: The ongoing recall campaign in Taiwan — where citizens are trying to collect enough signatures to trigger re-elections for a number of Chinese Nationalist Party (KMT) legislators — is orchestrated by the Democratic Progressive Party (DPP), or even President William Lai (賴清德) himself. The KMT makes the claim, and foreign media and analysts repeat it. However, they never show any proof — because there is not any. It is alarming how easily academics, journalists and experts toss around claims that amount to accusing a democratic government of conspiracy — without a shred of evidence. These
China on May 23, 1951, imposed the so-called “17-Point Agreement” to formally annex Tibet. In March, China in its 18th White Paper misleadingly said it laid “firm foundations for the region’s human rights cause.” The agreement is invalid in international law, because it was signed under threat. Ngapo Ngawang Jigme, head of the Tibetan delegation sent to China for peace negotiations, was not authorized to sign the agreement on behalf of the Tibetan government and the delegation was made to sign it under duress. After seven decades, Tibet remains intact and there is global outpouring of sympathy for Tibetans. This realization
RSS